Showing results (1731-1740 of 2,038) with videos related to
Sort By:
Pageof 204
NEJM Evidence|February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.JAMA Oncology|February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical TrialFelix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.Journal of Medicinal Chemistry|January 27, 2017
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging VirusesDustin Siegel, Hon C Hui, Edward Doerffler, et al.Nature|October 14, 2021
A bimodal burst energy distribution of a repeating fast radio burst sourceD Li, P Wang, W W Zhu, et al.Molecular Cancer|March 23, 2022
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancerC E Fletcher, L Deng, F Orafidiya, et al.Communications Biology|June 4, 2021
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differencesWalter Rayford, Alp Tuna Beksac, Jordan Alger, et al.Cell Reports|July 16, 2020
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in MiceAndrea J Pruijssers, Amelia S George, Alexandra Schäfer, et al.Oncotarget|November 23, 2017
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategyDaniel H Hovelson, Chia-Jen Liu, Yugang Wang, et al.NPJ Precision Oncology|July 7, 2025
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancerAnbarasu Kumaraswamy, Ya-Mei Hu, Joel A Yates, et al.Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistanceJoshi J Alumkal, Duanchen Sun, Eric Lu, et al.Pageof 204